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Abstract
Certain distinctive components of the severe systemic inflammatory syndrome are now well-
recognized to be common to malaria, sepsis, viral infections, and post-trauma illness. While their
connection with cytokines has been appreciated for some time, the constellation of changes that
comprise the syndrome has simply been accepted as an empirical observation, with no theory to
explain why they should coexist. New data on the effects of the main pro-inflammatory cytokines
on the genetic control of sickness behaviour can be extended to provide a rationale for why this
syndrome contains many of its accustomed components, such as reversible encephalopathy, gene
silencing, dyserythropoiesis, seizures, coagulopathy, hypoalbuminaemia and hypertriglyceridaemia.
It is thus proposed that the pattern of pathology that comprises much of the systemic inflammatory
syndrome occurs when one of the usually advantageous roles of pro-inflammatory cytokines –
generating sickness behaviour by moderately repressing genes (Dbp, Tef, Hlf, Per1, Per2 and Per3,
and the nuclear receptor Rev-erbα) that control circadian rhythm – becomes excessive. Although
reversible encephalopathy and gene silencing are severe events with potentially fatal consequences,
they can be viewed as having survival advantages through lowering energy demand. In contrast,
dyserythropoiesis, seizures, coagulopathy, hypoalbuminaemia and hypertriglyceridaemia may best
be viewed as unfortunate consequences of extreme repression of these same genetic controls
when the pro-inflammatory cytokines that cause sickness behaviour are produced excessively. As
well as casting a new light on the previously unrationalized coexistence of these aspects of systemic
inflammatory diseases, this concept is consistent with the case for a primary role for inflammatory
cytokines in their pathogenesis across this range of diseases.
Common ground in inflammatory disease, 
sickness behaviour and hibernation
The idea of acute infectious illness being caused by ram-
pant overproduction of inflammatory cytokines that, in
lower concentrations, mediate innate immunity, was first
argued a quarter of a century ago [1], and has generated a
large literature. Once recombinant tumour necrosis factor
(TNF) and interleukin-1 (IL-1) became available in the
late 1980s, and assays based on them replaced earlier
methods, the concept spread to other pro-inflammatory
cytokines, and from malaria and sepsis to viral and certain
autoimmune diseases. It is now also well-entrenched in
the literature of the post-trauma syndrome. Clearly, differ-
ent triggers for cytokine generation and release can be
expected to generate different foci, profiles, concentra-
tions and kinetics of these mediators – now numerous
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enough to form superfamilies – and thus clinical variation
within the same general principle is to be expected. But an
accepted fundamental pattern has emerged.
At a time of shifting perceptions on the interaction
between sickness and host activity (reviewed by Dantzer
[2]), Hart [3] argued that the distinctive behaviour of sick
humans and animals (lethargy, anorexia, depressed
motor activity etc.) was not simply another untoward
aspect of being ill. Instead, it was reasoned to be an adap-
tive syndrome that had evolved as a protective mechanism
to maximize chances of survival through encouraging the
sick animal to seek out and remain in a safe resting place,
and not search for food, until a survivable infectious epi-
sode had passed. Hart also proposed that sickness behav-
iour was caused by the inflammatory cytokines, TNF and
IL-1. This was later confirmed by others [4], and investi-
gated further through showing that IL-1 contributes sig-
nificantly to the anorexia caused by both endotoxin and
influenza infection [5,6]. The literature on this field is
now considerable. Indeed, Cavadini and co-workers [7]
note that this link between TNF and IL-1 and sickness
behaviour induced them to investigate if these inflamma-
tory cytokines suppress expression of the clock genes that
regulate circadian rhythm. It has recently [8] been realized
that the circadian cycle controls many more biological
functions than previously supposed.
Circadian rhythm and hibernation are variations of a
theme of genetic control of activity and metabolism, and
the degree to which these two clocks are functionally
linked is often studied [9]. The first example of a human
disease being thought of in these terms was ischaemic
heart disease, in which the concepts were adopted to
explain the self-protective downregulation of metabolic
function seen in cardiomyocytes after repeated bouts of
ischaemia. Like the seasonal hibernation seen in Arctic
mammals, it involves biochemical changes directed at
preserving energy, so in 1997 was termed myocardial
hibernation [10]. Functional hibernation as a survival
strategy in severe sepsis was proposed in 2003 [11], and
subsequently documented in myocytes in the mouse cae-
cal ligation and puncture model of systemic inflammatory
disease [12]. Levy's recent reasoning [13] that broadens
the possible relevance of cytokine-induced cardiomyocyte
hibernation to other organs is, as Singer suggested [11],
essentially sickness behaviour [3], with altered circadian
rhythm being considered in terms of cellular bioenerget-
ics. The consequence is to reduce demand for energy, in
the form of ATP, to a level commensurate with its supply.
Energy saving and the consequences of it being 
overdone
As outlined above, it seems reasonable that sickness
behaviour, including lowering the metabolic rate to con-
serve energy and turning off appetite to avoid the urge to
forage, will help tide the ill animal or human over an ill-
ness crisis. Recently, Cavadini and co-workers [7] reported
that TNF and IL-1β suppress the expression of genes (Dbp,
Tef, Hlf, Per1, Per2 and Per3) in vivo, and a nuclear receptor
(Rev-erbα) involved in controlling circadian rhythm. The
authors proposed that these cytokines thereby provide a
link between the fatigue associated with autoimmune dis-
eases, such as rheumatoid arthritis and Crohn's disease.
Nevertheless these cytokines, and others related to them,
can cause a much wider spectrum of harmful changes than
this [14]. Why these changes, so familiar from the litera-
ture and everyday observation, should occur as a group,
forming a distinct syndrome, currently lacks a rationale. It
was therefore considered how widely the implications of
severe sickness behaviour, through suppressed circadian
rhythm [7], might extend, and whether this approach
might be able to explain the composition of the severe sys-
temic inflammatory syndrome common to malaria, sep-
sis, viral infections, and also seen post-trauma. The
literature to date has focussed on mechanisms for individ-
ual changes, but not questioned why the mosaic contains
the components one is accustomed to observing.
In other words, are inflammatory cytokines simply
innately harmful in excess, pathophysiology arising from
excessive manifestation of the physiological roles they
possess when in trace amounts? Or, as suggested here (Fig-
ure 1), do the wider functions of the nuclear receptor
(Rev-erbα) and genes (Dbp, Tef, Hlf, Per1, Per2 and Per3)
[7] lead to an understanding of the syndrome to be
expected when a severe inflammatory illness occurs? In
documenting this suppression Cavadini and co-authors
administered, to mice, only a tenth of the dose of bacterial
lipopolysaccharide (LPS) required for a severe response in
this species. Accordingly, the literature was examined to
see whether these cytokine-suppressed nuclear receptor
and genes involved in circadian rhythm have other func-
tions that help us understand the pattern of changes rou-
tinely observed in the systemic inflammatory syndrome.
Reversible encephalopathy
An active brain consumes much more energy than any
other organ of similar size, largely through the demands
of the Na+/K+ ATPase that runs the cell membrane Na+/K+
pump [15]. Hence, it is likely to have been a prime conser-
vation site for any set of adaptive changes that have
evolved to conserve energy in order for the organism to
survive, whether at the level of sickness behaviour or
hibernation, both of which can be conveniently
approached in terms of altered circadian rhythm. The
fatigue of chronic inflammatory diseases such as rheuma-
toid arthritis is consistent with the capacity of TNF, to
which this fatigue is linked in the literature, to suppressMalaria Journal 2008, 7:208 http://www.malariajournal.com/content/7/1/208
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circadian rhythm genes [7]. Sleep saves energy and path-
ways that lead to sleep are induced by TNF [16] or IL-1β
[17]. Also, electroencephalogram (EEG) delta wave power
is decreased for several days when short interfering RNA
(siRNA) targeting TNF is microinjected into the primary
somatosensory cortex [18]. This is consistent with TNF
increasing cortical EEG delta wave power and, therefore,
[19] being involved in sleep regulation.
The TNF and IL-1β-susceptible genes through which these
changes are controlled have not been identified, but the
above observations imply the same principles apply as the
need to reduce ATP expenditure increases in urgency with
more severe illness, progressing through the increased
fatigue and sleep periods to the clinical signs of encepha-
lopathy, including coma, in severe malaria, sepsis, or
influenza. Clearly, this encephalopathy can be associated
with a harmful outcome in these systemic inflammatory
states, but its evolutionary function may simply be to save
energy. Indeed, this strategy is likely to be successful in,
for example, most adult cerebral malaria patients, who
recover with negligible neurological deficit if other organ
failure is not involved [20]. TNF [21] and IL-1 [22] are
increased in proportion to the degree of coma in falci-
parum malaria. The attractiveness of impaired conscious-
ness in this disease being based on awareness of the basic
physiology and broad effects of these and functionally
similar cytokines across acute disease in general – rather
than on primary vascular blockage by sequestered parasi-
tized red cells [23] – is enhanced by recent evidence, from
Papua New Guinea [24] and West Papua [25], of the
essentially non-sequestering Plasmodium vivax causing this
encephalopathy to the same degree as does Plasmodium
falciparum.
How might this coma come about? Biology's known gas-
eous signalling molecules offer possibilities, since they are
increased in inflammatory states, and induce a hiberna-
tion-like reversible state of suspended animation that pro-
tects against low ATP levels in Drosophila melanogaster
larvae (NO [26]), Caenorhabditis elegans (CO [27]) and
mice (H2S [28,29]). All three gases have the potential to
operate through inhibiting mitochondrial cytochrome
oxidase [30-32]. A striking contrast exists, however, in the
roles of these three gases in mammalian inflammation –
both NO [33] and CO [34] inhibit NF-κB, whereas H2S
upregulates it [35]. This dichotomy may prove to explain
why both NO and CO are anti-inflammatory in mice,
including protecting against the mouse model of malaria
encephalopathy [36,37], whereas H2S is pro-inflamma-
tory, increasing plasma TNF levels in mice [38], and its
inhibition protects in sepsis models [38,39]. These three
gases warrant a detailed comparative investigation in this
context.
LPS tolerance and inflammation-induced gene 
silencing
A major unaddressed question is the origin of the wide-
spread gene silencing that develops after the initial illness
crisis of severe systemic inflammation [40], including
The disease consequences of extreme circadian rhythm gene repression Figure 1
The disease consequences of extreme circadian rhythm gene repression. A comparison of the mild and severe con-
sequences of in vivo repression of PAR bZip clock genes (Dbp, Tef and Hlf), period genes (Per1, Per2, and Per3) and a nuclear 
factor (Rev-erbα) by inflammatory cytokines.
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H5N1 influenza in mice [41]. Immunosuppression is
common to haemoprotozoan diseases such as malaria
[42] and trypanosomiasis [43], as well as in sepsis [44],
influenza [45], and trauma [46]. Patients who survive the
initial acute effects of excessive levels of inflammatory
cytokines often succumb during a subsequent period of
immunological and metabolic shutdown, in a state vari-
ously termed anergy, immune paralysis, or monocyte
deactivation, with monocytes unable to generate HLA
antigens or enough cytokines for normal immunological
responses [47], let alone the excess that might be harmful
to the host [48]. In short, a systemic hyperinflammatory
response turns into a harmful hypoinflammatory state of
unknown origin [49]. Explanations for these events in
sepsis have included anti-inflammatory cytokines out-
producing inflammatory cytokines [50] and severe lym-
phoid cell apoptosis [51]. However, both pro- and anti-
inflammatory cytokines proved to switch off as the disease
progresses [52], and the point of maximum T cell anergy
correlates to a diminished apoptotic response [53].
LPS tolerance is a common model for gene silencing, and
repressed gene expression, arising from disrupted tran-
scription, is as widespread in LPS tolerance as in severe
inflammatory disease. Indeed the two coincide, with
patients recovering from malaria being tolerant to LPS
[54] as well as to high loads of malaria parasites [55]. In
landmark studies in 1975 Lewis Thomas widened our
awareness of the broad relevance of the changes seen in
LPS tolerance by studying it in parallel to tolerance to
haemorrhagic shock and trauma shock [56]. Arguably,
therefore, LPS tolerance is simply a particular way of
detecting a process common to many disease states. For
instance, the patterns of NF-κB expression in sepsis and
LPS tolerance closely resemble each other [57], and
monocyte inactivation is as generalized, with the same
characteristics, in LPS tolerance as in chronic sepsis [58].
LPS tolerance, and therefore sepsis gene silencing, has a
functional link to the theme of this review, in that it has a
distinct circadian rhythm [59,60], and can be created by
depleting mice of Per2, one of the circadian genes that
TNF suppresses [7].
More recently, LPS tolerance has been explained in terms
of RelB induction generating transcriptionally inactive
NF-κB p65/RelB heterodimers [61] and epigenetic silenc-
ing of TNF [62]. The latter seems a particularly cogent
argument, with LPS tolerant, or silenced, cells exhibiting
repressed production of TNF mRNA, retained binding of
heterochromatin binding protein 1α, sustained methyla-
tion of histone H3 lysine 9, reduced phosphorylation of
histone H3 serine 10, and diminished binding of NF-κB
RelA/p65 to the TNF promoter. This group has combined
these elements, which are consistent with basic studies on
gene silencing [63], into a compelling case to explain this
phenomenon in severe systemic inflammation [40]. It is,
moreover, consistent with the hypoinflammatory state
being a logical consequence of the earlier cytokine storm
that caused the excessive sickness behaviour.
Changes less likely to have survival advantage
Dyserythropoiesis
A significant contribution is made to anaemia, in both
acute and chronic inflammatory states, by defective gener-
ation of new red cells in bone marrow, or dyserythropoi-
esis. It can be reproduced by injecting TNF [64], and not
surprisingly has been recorded in a range of infectious
states in which pro-inflammatory cytokines are increased,
including malaria [65], trypanosomiasis [66] and viral
diseases [67-69]. As in many other tissues, the bone mar-
row's haemopoietic cells are governed by time-dependent
variations in clock gene expression. This includes Per1,
Per2, and the nuclear receptor Rev-erbα [70], all three of
which are included in the nuclear elements shown to be
suppressed by TNF [7]. This suppression gives a pathway
whereby TNF could reduce haemopoietic activity in infec-
tious diseases. It can be viewed as part of a generic attempt
to save energy, in which any initial savings would soon
become a liability as haematocrit, and therefore the capac-
ity to carry oxygen in the circulation, falls.
Seizures
Febrile seizures are traditionally attributed to fever itself,
rather than fever and seizures being visualized as having a
common cause. Seizures are particularly common in
malarial illness. In one large study [71] based in Kenya,
69% of patients experienced them, and other reports from
West Africa record a considerably higher incidence. They
are also frequently observed in paediatric sepsis [72], burn
injury [73], and a range of acute severe viral diseases,
including influenza [74] and Lassa fever [75].
An unexpected development in understanding the origin
of certain types of seizures came from the realization, sev-
eral years ago [76], that mice with deletions of the genes
for three circadian PARbZip transcription factors, DBP,
HLF and TEF, are highly susceptible to generalized spon-
taneous and audiogenic seizures. Moreover, fits were four
times as likely to occur in the major sleep period of the cir-
cadian cycle than in its major active period. These authors
identified Pdxk as a target gene of these transcription fac-
tors, noting the role of this gene in the generation of pyri-
doxal phosphate, a coenzyme in the synthesis of
neurotransmitters such as γ-aminobutyric acid, serotonin
and dopamine. Through the genes for these three tran-
scription factors being among those recently reported to
be suppressed by TNF and IL-1β [7], this mechanism for
seizures is now linked to infectious disease and fever sei-
zures, since these and similar pyrogenic cytokines domi-
nate disease pathogenesis. These authors found anMalaria Journal 2008, 7:208 http://www.malariajournal.com/content/7/1/208
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appreciable degree of down-regulation by a dose of
cytokine a tenth of that required to make mice seriously
ill, so these two cytokines warrant investigation as the
cause of seizures, through Dbp, Tef, and Hlf downregula-
tion, in circumstances in which levels of these cytokines
are raised, such as severe haemoprotozoal, bacterial and
viral diseases.
Coagulopathy
Coagulopathy is another characteristic component of the
systemic inflammatory syndrome. As well as being detect-
able in human volunteers receiving parenteral TNF [77], it
is, like seizures, common to malaria [78], sepsis [79], and
viral diseases (eg dengue [80], Ebola [81] and influenza
[82]). Plasminogen activator inhibitor type 1 (PAI-1),
which retards the generation of plasmin, thereby adding
to coagulopathy by slowing clot dissolution, is a major
regulator of the fibrinolytic system. It is expressed with a
circadian rhythmicity, peaking in the early morning. The
nuclear receptor Rev-erbα, a core component of the circa-
dian loop, causes this cyclic expression of human PAI-1
gene expression through two Rev-erbα binding sites in the
PAI-1 promoter [83]. Hence, the capacity of TNF to sup-
press Rev-erbα, and thus circadian rhythm [7], may also
explain why it enhances coagulopathy [77], and why this
occurs in protozoal, bacterial, and viral diseases. Higher
levels of PAI-1 predict a poor outcome in patients with
sepsis [84]. Thus, it is argued here that the coagulopathy
of these systemic disease states is a further example of sick-
ness behaviour, i.e. circadian rhythm shutdown, taken to
harmful extremes.
Hypoalbuminaemia
Plasma albumin has several important biological func-
tions, including being an extracellular transition metal
ion-binding and radical-scavenging antioxidant, and an
important contributor to plasma osmolarity. Its level is
therefore normally controlled within tight limits. Levels
are characteristically low in systemic inflammatory states,
and this decrease can also be accounted for by this pro-
posal. Hypoalbuminaemia occurs routinely in malaria
[85], sepsis [86,87], various severe viral diseases (eg
Korean haemorrhagic fever [88], dengue [89], Ebola [90],
viral hepatitis [91], SARS [92]), visceral leishmaniasis [93]
and trauma [94]. Serum albumin level is an independent
indicator of outcome in severe sepsis [95], so much so that
it was included in the criteria when the APACHE scoring
system was upgraded from II to III [96]. The liver-specific
albumin gene is positively regulated by Dbp [97], one of
the circadian genes that TNF suppresses [7]. TNF has been
demonstrated, in picomolar concentrations, to reduce
albumin production by human hepatocytes [98].
Hypertriglyceridaemia
Usually, and for sound metabolic reasons, the concentra-
tion of triglycerides in plasma is closely regulated. Circu-
lating levels can be increased by exogenous TNF [99], and
this cytokine has been shown to bring this about in ther-
mal injury [100]. Thus hypertriglyceridaemia can be
expected in diseases in which TNF is acutely increased, as
documented in malaria [101] and sepsis [86,102]. How-
ever, no reference exists to circulating triglyceride levels
having been examined in viral diseases. Since TNF sup-
presses the nuclear receptor Rev-erbα [7], and hypertrig-
lyceridaemia occurs in Rev-erbα KO mice [103], the
presence of this change in the systemic inflammatory syn-
drome is predictable.
Consistent with a primary cytokine origin of 
systemic disease
These arguments strengthen the concept that the pro-
inflammatory cytokines are the primary driver of the
pathophysiology of severe infectious, including malaria,
and post-trauma illness. An alternative view, that each
pathogen causes disease through a different primary
mechanism (eg death of viral-infected host cells or vascu-
lature blockage by parasitized red cells in malaria [23]),
with cytokines providing only non-specific changes such
as fever, still exists. This view is further weakened by the
above literature and reasoning, since it is difficult to credit
vascular obstruction (falciparum malaria) or cell death
(viral infection) with the ability to generate the above
changes, such as coagulopathy, hypoalbuminaemia or
immunosuppression, in a single infectious disease, let
alone a range of them, or post-trauma.
Conclusion
While sickness behaviour, comprising a series of changes
caused through pro-inflammatory cytokines shutting
down circadian rhythm, has survival advantages, its more
intense expression in severe disease generates a range of
more harmful alterations, recognizable as the severe sys-
temic inflammatory response. These are controlled by
more severe effects of the same cytokines (TNF and IL-1β)
affecting the same genes and nuclear receptor(s) as sup-
press circadian rhythm. Accordingly, the coexistence of
reversible encephalopathy, gene silencing, dyserythropoi-
esis, seizures, coagulopathy, hypoalbuminaemia and
hypertriglyceridaemia in severe infectious disease, includ-
ing malaria, can best be understood as an extreme form of
sickness behaviour. It is further proposed that this pattern,
familiar in such conditions, has persisted in evolution
because it has a survival advantage when, most com-
monly, the syndrome is less severe. In terms of a basis for
developing treatments for human disease, this implies
that the observed hypoinflammatory changes seen in
these conditions require no primary explanation other
than they are logical consequences of excess earlier pro-Malaria Journal 2008, 7:208 http://www.malariajournal.com/content/7/1/208
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duction of pro-inflammatory cytokines, although local
variations in secondary, cytokine-induced mechanisms
occur.
As knowledge of the range of genes controlled by the
superfamilies of pro-inflammatory cytokines and the
genetic control of pathological changes both expand, it
seems likely that other components of the systemic
inflammatory syndrome will be added to the list begun in
this paper.
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